Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Claudia Andreetta"'
Autor:
Martina Arcieri, Veronica Tius, Claudia Andreetta, Stefano Restaino, Anna Biasioli, Elena Poletto, Giuseppe Damante, Alfredo Ercoli, Lorenza Driul, Anna Fagotti, Domenica Lorusso, Giovanni Scambia, Giuseppe Vizzielli
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
About 50% of High Grade Serous Ovarian Cancer exhibit a high degree of genomic instability due to mutation of genes involved in Homologous Recombination (HRD) and such defect accounts for synthetic lethality mechanism of PARP inhibitors (PARP-i). Sev
Externí odkaz:
https://doaj.org/article/3d1bed078930434ca0103b78ab067442
Autor:
Gabriella Macchia, Francesca Titone, Stefano Restaino, Martina Arcieri, Giulia Pellecchia, Claudia Andreetta, Lorenza Driul, Giuseppe Vizzielli, Donato Pezzulla
Publikováno v:
Healthcare, Vol 11, Iss 17, p 2413 (2023)
With a 5-year survival rate of fewer than 50%, epithelial ovarian carcinoma is the most fatal of the gynecologic cancers. Each year, an estimated 22,000 women are diagnosed with the condition, with 14,000 dying as a result, in the United States. Over
Externí odkaz:
https://doaj.org/article/e4416fc88a8c46a18ee276759576eaf8
Autor:
Stefano Restaino, Jessica Mauro, Silvia Zermano, Giulia Pellecchia, Laura Mariuzzi, Maria Orsaria, Francesca Titone, Anna Biasioli, Monica Della Martina, Claudia Andreetta, Elena Poletto, Martina Arcieri, Alessandro Buda, Lorenza Driul, Giuseppe Vizzielli
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveHigh-grade serous ovarian carcinoma (HGSC) often presents lymph node involvement. According to the paths of lymphatic drainage, the most common site of nodal metastasis is in the aortic area. However, pelvic lymph nodes are also involved and
Externí odkaz:
https://doaj.org/article/d70c84bac9264c40afe5b08960c61623
Autor:
Lucia Bortot, Giada Targato, Claudia Noto, Marco Giavarra, Lorenza Palmero, Diego Zara, Elisa Bertoli, Arianna Dri, Claudia Andreetta, Gaetano Pascoletti, Elena Poletto, Stefania Russo, Luca Seriau, Mauro Mansutti, Carla Cedolini, Debora Basile, Gianpiero Fasola, Marta Bonotto, Alessandro Marco Minisini
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundA multidisciplinary team meeting (MDM) approach in breast cancer (BC) management is a standard of care. One of the roles of MDMs is to identify the best diagnostic and therapeutic strategies for patients (pts) with new diagnosis of early BC
Externí odkaz:
https://doaj.org/article/1d1ee3c76c3044ac8d6078ed2cca391f
Autor:
Stefano Restaino, Giulia Pellecchia, Alice Poli, Martina Arcieri, Claudia Andreetta, Laura Mariuzzi, Maria Orsaria, Anna Biasioli, Monica Della Martina, Sergio Giuseppe Intini, Giovanni Scambia, Lorenza Driul, Giuseppe Vizzielli
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 7, p 2468 (2023)
Hepatoid carcinoma of the ovary (HCO) is a tumor that resembles, both histologically and cytologically, hepatocarcinoma (HCC) in a patient with a non-cirrhotic liver not involved by the disease. Hepatoid carcinoma is an extremely rare histologic subt
Externí odkaz:
https://doaj.org/article/278968ce5c144983942a0feda1481250
Autor:
Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, Elisa Picardo, Francesco Raspagliesi, Claudia Andreetta, Elena Maldi, Grazia Artioli, Serafina Mammoliti, Lucia Zanchi, Angelica Sikokis, Nicoletta Biglia, Alessandro Parisi, Vincenzo Dario Mandato, Claudia Carella, Gennaro Cormio, Marco Marinaccio, Andrea Puppo, Biagio Paolini, Lucia Borsotti, Giulia Scotto, Margherita Turinetto, Dario Sangiolo, Massimo Di Maio, Giorgio Valabrega
Publikováno v:
Cancers, Vol 15, Iss 4, p 1032 (2023)
Background: There is compelling need for novel biomarkers to predict response to PARP inhibitors (PARPi) in BRCA wild-type (WT) ovarian cancer (OC). Methods: MITO 37 is a multicenter retrospective study aiming at correlating Ki67 expression at diagno
Externí odkaz:
https://doaj.org/article/6f3569dc15f5475d9beb727c4b8256ce
Autor:
Stefano Restaino, Chiara Paglietti, Martina Arcieri, Anna Biasioli, Monica Della Martina, Laura Mariuzzi, Claudia Andreetta, Francesca Titone, Giorgio Bogani, Diego Raimondo, Federica Perelli, Alessandro Buda, Marco Petrillo, Pantaleo Greco, Alfredo Ercoli, Francesco Fanfani, Giovanni Scambia, Lorenza Driul, Giuseppe Vizzielli, The Udine Hospital Gynecological-Oncological Tumor Board Group
Publikováno v:
Cancers, Vol 15, Iss 4, p 1091 (2023)
Endometrial cancer is the most common gynecological malignancy in Europe and its management involves a variety of health professionals. In recent years, big discoveries were made concerning the management of patients diagnosed with endometrial cancer
Externí odkaz:
https://doaj.org/article/eb5f6d72c18e4af6b88cdd64a7f79bf5
Autor:
Stefano Restaino, Jessica Mauro, Stefano Cianci, Alessandro Buda, Claudia Andreetta, Elena Poletto, Enrico Maria Pasqual, Alice Poli, Cosimo Vittorio Agrimi, Doriana Armenise, Alice Buzzelli, Domenico Caccamo, Lorenza Driul, Giuseppe Vizzielli
Publikováno v:
Clinical and Experimental Obstetrics & Gynecology, Vol 49, Iss 6, p 143 (2022)
Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with interval debulking surgery (IDS) constitutes an adjunctive treatment strategy in advanced ovarian cancer (AOC). This approach is based on the concept of perfusing chemotherap
Externí odkaz:
https://doaj.org/article/efa8d3eb2e3a472aabcd2a3b43b9cd5c
Autor:
Sandro Pignata, Giovanni Scambia, Clorinda Schettino, Laura Arenare, Carmela Pisano, Davide Lombardi, Ugo De Giorgi, Claudia Andreetta, Saverio Cinieri, Carmine De Angelis, Domenico Priolo, Claudia Casanova, Marta Rosati, Filippo Greco, Elena Zafarana, Ilaria Schiavetto, Serafina Mammoliti, Sabrina Chiara Cecere, Vanda Salutari, Simona Scalone, Alberto Farolfi, Marilena Di Napoli, Domenica Lorusso, Piera Gargiulo, Daniela Califano, Daniela Russo, Anna Spina, Rossella De Cecio, Paolo Chiodini, Francesco Perrone, Valentina Accinno, Chiara Altavilla, Giovanna Antonelli, Grazia Artioli, Francesco Avola, Bonifacio Barbara, Valentina Barbato, Michele Bartoletti, Simona Bevilacqua, Roberto Bordonaro, Oriana Borghese, Gaetano Buonfanti, Floriana Camarda, Giuliana Canzanella, Vittoria Carbone, Maria Rita Carbone, Giulia Carlo Stella, Chiara Cassani, Fabrizio Castagna, Monica Cattaneo, Margherita Cinefra, Nicoletta Colombo, Serena Corsetti, Monia Dall'Agata, Maria D'Amico, Gennaro Daniele, Elvira De Marino, Giovanni De Matteis, Sabino De Placido, Gabriella Del Bene, Antonia Del Giudice, Francesca Del Monte, Michele Del Sesto, Maddalena Donini, Giuliana Drudi, Gianluca Falcone, Adolfo Favaretto, Giulia Ferrera, Manuela Florio, Valeria Forestieri, Maria Stella Gallo, Ciro Gallo, Francesca Garibaldi, Fabiana Gerevini, Viola Ghizzoni, Maria Olga Giganti, Anna Gimigliano, Elena Giudice, Nicoletta Gnocchi, Adriano Gravina, Stefano Greggi, Maria Laura Iaia, Annalisa Ilardi, Gelsomina Iovine, Gabriella Ippoliti, Giulia Irollo, Ilenia Isidori, Mariateresa Lapresa, Giuseppe Lavenia, Laura Longhitano, Bortot Lucia, Gabriella Luzi, Sara Mariano, Valentina Marino, Giovanna Marrapese, Marilena Martino, Roberta Matocci, Enrica Mazzoni, Daniela Mercuri, Maria Mirto, Giovanna Mollo, Abbondanza Montinaro, Marta Moscatelli, Anna Maria Mosconi, Lucia Musacchio, Nicoletta Nanni, Pamela Natalucci, Milena Sabrina Nicoloso, Michele Orditura, Gabriella Maria Parma, Rodolfo Passalacqua, Michela Pelone, Maria Teresa Perri, Bruno Perrucci, Alessandra Piancastelli, Maria Carmela Piccirillo, Antonio Piccolo, Stefania Rapisardi, Giorgia Ravaglia, Teresa Ribecco, Caterina Ricci, Marianna Roccio, Fiorella Romano, Daniela Sambataro, Alfonso Savio, Ada Sbriglia, Cono Scaffa, Concetta Sergi, Francesca Sgandurra, Roberto Sorio, Stefano Stabile, Gianna Tabaro, Margherita Tambaro, Stefano Tamberi, Angelica Tecchiato, Angela Maria Trujillo, Eleonora Zaccarelli
Publikováno v:
The Lancet Oncology. 24:286-296
Background: Adding immunotherapy to first-line chemotherapy might improve outcomes for patients with advanced or recurrent endometrial cancer. We aimed to compare carboplatin and paclitaxel versus avelumab plus carboplatin and paclitaxel as first-lin
Autor:
Ambrogio P. Londero, Maria Orsaria, Luigi Viola, Stefania Marzinotto, Serena Bertozzi, Elena Galvano, Claudia Andreetta, Laura Mariuzzi
Publikováno v:
Human Pathology. 127:92-101
Survivin was previously associated with tumor stage and grade in ovarian cancer and interfered with the tumor's drug sensitivity. In addition, Survivin expression was found to be regulated by the Sonic hedgehog (Shh) pathway, Krüppel-like factor (KL